Barclays’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-456
| Closed | -$7K | – | 4225 |
|
|
2016
Q2 | $7K | Sell |
456
-2,100
| -82% | -$32.2K | ﹤0.01% | 3082 |
|
|
2016
Q1 | $31K | Buy |
2,556
+2,041
| +396% | +$24.8K | ﹤0.01% | 2681 |
|
|
2015
Q4 | $8K | Sell |
515
-8,802
| -94% | -$137K | ﹤0.01% | 2854 |
|
|
2015
Q3 | $140K | Buy |
9,317
+8,863
| +1,952% | +$133K | ﹤0.01% | 2259 |
|
|
2015
Q2 | $11K | Sell |
454
-626
| -58% | -$15.2K | ﹤0.01% | 3273 |
|
|
2015
Q1 | $25K | Sell |
1,080
-2,997
| -74% | -$69.4K | ﹤0.01% | 3032 |
|
|
2014
Q4 | $102K | Sell |
4,077
-4,279
| -51% | -$107K | ﹤0.01% | 2696 |
|
|
2014
Q3 | $258K | Sell |
8,356
-479
| -5% | -$14.8K | ﹤0.01% | 2201 |
|
|
2014
Q2 | $221K | Buy |
8,835
+2,774
| +46% | +$69.4K | ﹤0.01% | 2342 |
|
|
2014
Q1 | $140K | Buy |
6,061
+4,824
| +390% | +$111K | ﹤0.01% | 2582 |
|
|
2013
Q4 | $31K | Sell |
1,237
-4,082
| -77% | -$102K | ﹤0.01% | 3581 |
|
|
2013
Q3 | $106K | Buy |
5,319
+4,451
| +513% | +$88.7K | ﹤0.01% | 2920 |
|
|
2013
Q2 | $18K | Buy |
+868
| New | +$18K | ﹤0.01% | 3729 |
|